The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus...

Value in Health 2013 / 11 Vol. 16; Iss. 7

The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Glipizide in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales

Charokopou, M., McEwan, P., Lister, S., Callan, L., Bergenheim, K., Tolley, K., Roudaut, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2013.08.677
Date:
November, 2013
File:
PDF, 58 KB
english, 2013
Conversion to is in progress
Conversion to is failed